🇺🇸 FDA
Patent

US 8809268

Combination therapy to combat helminth resistance

granted A61KA61K31/425A61K31/506

Quick answer

US patent 8809268 (Combination therapy to combat helminth resistance) held by The Regents of the University of California expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/425, A61K31/506, A61K35/74, A61K38/164